Ornithine transcarbamylase deficiency is a rare genetic condition where the liver cannot properly remove ammonia from the blood, potentially causing life-threatening damage to the brain if left untreated.

When we eat protein, our bodies naturally produce ammonia as a waste product. Normally, the liver quickly converts this ammonia into a harmless substance called urea, which leaves the body through urine. But in people with ornithine transcarbamylase deficiency, this conversion process doesn’t work properly. The enzyme that should handle this critical task is either missing or doesn’t function correctly, allowing ammonia to build up in the bloodstream. Because the brain is especially vulnerable to high ammonia levels, this buildup can cause serious and permanent damage if not addressed quickly.^[1]

This condition belongs to a group of disorders called urea cycle disorders, which are problems with the body’s ability to process nitrogen and eliminate it safely. Among all these disorders, ornithine transcarbamylase deficiency stands out as the most common one that families may encounter. Despite being the most frequent, it remains quite rare overall, affecting a small portion of the population.^[2]

How Common Is This Condition

Ornithine transcarbamylase deficiency affects somewhere between 1 in 14,000 and 1 in 77,000 people, depending on which estimates you look at. The wide range exists partly because people with milder forms of the condition may never come to medical attention, making them harder to count. Those with severe symptoms that appear shortly after birth are more likely to be diagnosed and included in these statistics, while others with late-onset forms might go unrecognized for years or even decades.^[3]

This condition affects males more frequently and more severely than females. The reason lies in how the condition is inherited. The genetic change that causes ornithine transcarbamylase deficiency sits on the X chromosome, one of the two chromosomes that determine biological sex. Boys have only one X chromosome, so if that single copy carries the problematic gene, they will develop the disease. Girls, on the other hand, have two X chromosomes. Even if one carries the abnormal gene, the other may still function normally, often protecting them from severe symptoms. However, this doesn’t mean girls and women are completely safe—approximately 10 to 20 percent of female carriers do develop symptoms at some point in their lives.^[4]

What Causes This Disorder

Ornithine transcarbamylase deficiency happens because of changes in the OTC gene, which provides instructions for making the ornithine transcarbamylase enzyme. Scientists have identified at least 400 different DNA changes that can cause this condition. Each of these changes disrupts the enzyme’s ability to do its job of converting ammonia into a safer substance that the body can eliminate.^[12]

The genetic changes can come about in two different ways. In many cases—somewhere between 36 and 80 percent depending on the country—the DNA change is inherited. This means a baby receives the altered gene from their mother. Male children who inherit this change will develop the disease, while female children become carriers who may or may not have symptoms. In other cases, the DNA change happens spontaneously during fetal development. These are called de novo mutations, meaning they occur randomly and were not passed down from either parent.^[12]

Interestingly, about one in five cases of ornithine transcarbamylase deficiency don’t show any detectable DNA change even with modern genetic testing. This doesn’t mean the diagnosis is wrong—it simply means that current testing methods have limitations and cannot yet identify every possible genetic alteration that causes the condition.^[2]

Who Is At Higher Risk

Because ornithine transcarbamylase deficiency follows an X-linked inheritance pattern, males face the highest risk of developing severe disease. If a mother carries the genetic change on one of her X chromosomes, each of her sons has a 50 percent chance of inheriting that altered gene and developing the condition. Each daughter has a 50 percent chance of becoming a carrier like her mother.^[3]

Female carriers face their own risks. While many remain symptom-free throughout their lives, others develop symptoms ranging from mild to severe. The severity depends on a biological process called X-inactivation. In every female cell, one X chromosome is randomly “turned off.” If the chromosome carrying the normal gene is turned off in most liver cells, the woman will have more symptoms. If the chromosome with the altered gene is mostly turned off, she may have few or no problems.^[3]

Recognizing The Symptoms

The symptoms of ornithine transcarbamylase deficiency vary dramatically depending on when they first appear and how severe the enzyme deficiency is. The condition generally falls into three categories based on age of onset: neonatal (appearing in the first 30 days of life), intermediate (appearing between 1 month and 16 years), and late-onset (appearing after age 16, sometimes as late as age 60).^[4]

In the most severe form, which typically affects newborn boys, symptoms emerge within the first few days after birth, most commonly on the second or third day of life. At first, the baby may seem normal, but symptoms develop rapidly as protein intake begins. The infant becomes increasingly lethargic, meaning they lack energy and seem excessively sleepy or unresponsive. They may refuse to eat or feed poorly, and begin vomiting. Parents might notice unusual irritability or that their baby feels “floppy” due to weak muscle tone. Without immediate treatment, the condition can progress to seizures, breathing problems, difficulty maintaining body temperature, and potentially coma.^[1][7]

Children who develop symptoms later in infancy or childhood often show a somewhat different picture. They may experience repeated episodes of vomiting, confusion, or delirium. Some develop headaches or show unusual behavior changes. Loss of coordination while walking is another possible sign. Many of these children have growth delays and may show an aversion to protein-rich foods, instinctively avoiding the very foods that trigger their symptoms. If you take a careful dietary history from families of children with undiagnosed ornithine transcarbamylase deficiency, you’ll often find this pattern of protein avoidance.^[5][4]

Adults with late-onset disease can experience many of the same symptoms seen in children, along with additional ones. Nausea, migraines, trouble speaking clearly, hallucinations, and vision disturbances may all occur. Some people experience episodes of altered mental status where they seem confused, behave erratically, or have a reduced level of consciousness. These episodes can be triggered by eating too much protein, by illness or infection, by surgery, or by certain medications.^[3][4]

It’s crucial to understand that ammonia toxicity affects only the brain—other organs can handle elevated ammonia levels without problems. This means that all the serious symptoms of ornithine transcarbamylase deficiency stem from the brain’s unique vulnerability to this substance. The longer ammonia remains elevated, the greater the risk of permanent neurological damage. This is why the speed of treatment matters far more than the absolute ammonia level in determining long-term outcomes.^[5]

Preventing Complications

For families with a known history of ornithine transcarbamylase deficiency, genetic counseling provides valuable information about the risks to future children. A genetic counselor can explain inheritance patterns, discuss testing options during pregnancy, and help couples understand their choices. This specialized counseling is particularly important because the condition can be so serious if not managed from birth.^[8]

Some states now screen newborns for ornithine transcarbamylase deficiency as part of routine newborn screening programs. Early identification through screening allows treatment to begin immediately, before dangerous ammonia levels develop. When the condition is caught early and management follows carefully, many of the serious health problems can be prevented or lessened significantly.^[8]

Once someone has been diagnosed with ornithine transcarbamylase deficiency, prevention focuses on avoiding situations that trigger ammonia buildup. This means following dietary recommendations carefully, taking prescribed medications consistently, staying up to date with immunizations to prevent infections, and avoiding certain medications that can worsen the condition. People with this diagnosis should keep their immunizations current to reduce the risk of infections that could trigger a crisis. They should also carry information about their condition—often called an acute illness protocol—that can be brought to the emergency room if needed.^[8][14]

For women with ornithine transcarbamylase deficiency, pregnancy requires extra caution. Pregnant women must work closely with both a dietician and their healthcare providers throughout pregnancy and the period after delivery. The physical stress of pregnancy can trigger dangerous ammonia levels, so careful monitoring and dietary adjustments become even more critical during this time.^[12][18]

How The Body Changes In This Disease

To understand what goes wrong in ornithine transcarbamylase deficiency, it helps to know how the body normally handles nitrogen. Unlike fats and carbohydrates, which can be stored for later use, protein exists in a constant state of balance between being built up and broken down. When the body has more protein than it needs—either from eating too much protein or from breaking down body proteins during illness or stress—amino acids are dismantled and release nitrogen. This nitrogen circulates as ammonia, a toxic substance that must be eliminated.^[14]

The liver handles this task through a series of chemical reactions called the urea cycle. This cycle takes place in liver cells, specifically within structures called mitochondria. The ornithine transcarbamylase enzyme performs a crucial step in this cycle: it combines two substances, ornithine and carbamoyl phosphate, to create citrulline. This allows the cycle to continue forward, eventually converting ammonia into urea, which the kidneys can safely eliminate in urine.^[14]

When the ornithine transcarbamylase enzyme is missing or doesn’t work properly, this crucial step cannot happen. The urea cycle stalls. Carbamoyl phosphate, which should have been used to make citrulline, accumulates and gets diverted into a different pathway, producing excessive amounts of a substance called orotic acid. Meanwhile, ammonia continues to build up because it cannot be converted to urea. Some ammonia temporarily gets stored in a molecule called glutamine, but this is only a short-term solution. As both ammonia and glutamine rise in the blood, toxic effects begin, especially in the brain.^[14]

The brain is uniquely sensitive to ammonia for several reasons. High ammonia levels disrupt brain energy metabolism, interfere with neurotransmitter function, and cause swelling of brain cells. This leads to metabolic encephalopathy, a term meaning brain dysfunction caused by metabolic abnormalities. The swelling and dysfunction can progress rapidly, leading to confusion, loss of consciousness, seizures, and potentially permanent brain injury or death if not treated promptly.^[4]

The severity of these changes depends partly on how much enzyme activity remains. People with complete or near-complete enzyme deficiency develop severe symptoms early in life. Those with some residual enzyme function may do well for years, only experiencing problems when faced with particular stressors that overwhelm their limited capacity to process ammonia. This explains why some people don’t develop symptoms until adolescence or even adulthood.^[7]